Behnes Michael, Ünsal Melike, Hoffmann Ursula, Fastner Christian, El-Battrawy Ibrahim, Lang Siegfried, Mashayekhi Kambis, Lehmann Ralf, Borggrefe Martin, Akin Ibrahim
First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
Internal Medicine Clinic II, Helios Vogtland Klinikum Plauen, Academic Teaching Hospital of Leipzig University, Plauen, Germany.
Clin Med Insights Cardiol. 2015 Nov 3;9:97-103. doi: 10.4137/CMC.S31932. eCollection 2015.
Bleeding events after percutaneous coronary interventions (PCI) are associated with patients' age, gender, and the presence of chronic kidney disease, antithrombotic treatment, as well as arterial access site. Patients being treated by PCI using radial access site are associated with an improved prognosis. However, the safety of femoral closure devices has never been compared to radial compression devices following PCI. Therefore, the aim of this study is to evaluate the safety of femoral closure compared to radial compression devices in patients treated by PCI envisaging access site bleedings as well as short- and long-term prognostic outcomes.
The Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) study is a single-center observational study comparing 400 consecutive patients undergoing PCI either using radial compression devices (TR Band™) or femoral closure devices (Angio-Seal™) at the corresponding access site. The primary outcome consists of the occurrence of vascular complications at the arterial access site, including major bleedings as defined by common classification systems. Secondary outcomes consist of the occurrence of adverse cardiac events, including all-cause mortality, target lesion revascularization, and target vessel revascularization during 30 days and 12 months of follow-up.
Study enrollment was initiated in February 2014. The enrollment phase is expected to last until May 2015.
The FERARI study intends to comparatively evaluate the safety and prognostic outcome of patients being treated by radial or femoral arterial closure devices following PCI during daily clinical practice.
经皮冠状动脉介入治疗(PCI)后的出血事件与患者的年龄、性别、慢性肾病的存在、抗血栓治疗以及动脉穿刺部位有关。采用桡动脉穿刺部位进行PCI治疗的患者预后较好。然而,PCI术后股动脉闭合装置的安全性从未与桡动脉压迫装置进行过比较。因此,本研究的目的是评估在PCI治疗的患者中,与桡动脉压迫装置相比,股动脉闭合装置的安全性,同时考虑穿刺部位出血以及短期和长期预后结果。
经皮冠状动脉介入治疗相关的股动脉闭合与桡动脉压迫装置(FERARI)研究是一项单中心观察性研究,比较了400例连续接受PCI治疗的患者,这些患者在相应的穿刺部位分别使用桡动脉压迫装置(TR Band™)或股动脉闭合装置(Angio-Seal™)。主要结局包括动脉穿刺部位血管并发症的发生,包括常见分类系统定义的大出血。次要结局包括不良心脏事件的发生,包括随访30天和12个月期间的全因死亡率、靶病变血管重建和靶血管血管重建。
研究于2014年2月开始入组。入组阶段预计持续至2015年5月。
FERARI研究旨在比较评估在日常临床实践中,PCI术后采用桡动脉或股动脉闭合装置治疗患者的安全性和预后结果。